Alisertib is an orally available Drug with potential antineoplastic activity. It is a selective inhibitor of aurora A kinase developed by Takeda. Reference standards of Alisertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Alisertib-API [catalogue_number] => PA 01 2730000 [category_ids] => ,123,81,78,75,76,82, [chemical_name] => [weight] => 518.93 [form] => C27H20ClFN4O4 [cas] => 1028486-01-2 [pslug] => 1028486-01-2-alisertib-pa012730000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 01 2730000
CAS :
Molecular Formula : C27H20ClFN4O4
Molecular Weight : 518.93
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....